Application 074721
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CONCENTRATE;ORAL | EQ 10MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54838-512 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-512 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 54838-512 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 68151-5656 | Doxepin Hydrochloride | Doxepin Hydrochloride | Carilion Materials Management | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 30691 | ORIG | 1998-12-29 |